In Brief: ATS Medical
This article was originally published in The Gray Sheet
Executive Summary
ATS Medical: Receives marketing approval for its Open Pivot mechanical heart valve in Japan, where sales are being handled by Century Medical, Inc. ATS submitted an investigational device exemption for the valve to FDA in October 1994 ("The Gray Sheet" March 6, 1995, p. 16) but has not initiated U.S. clinical trials due to agency requests for additional information on issues such as mechanical data, durability and in vitro testing. ATS says the valve has been implanted in approximately 10,000 subjects outside the U.S...
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.